Enrolling by invitationPhase 3
Tests dexamethasone injections during cataract surgery in mild to moderate diabetic eye disease
Tests dexamethasone eye injections during cataract surgery in people with diabetic retinopathy.
Plain-language title generated from the registry record
Registry title: Intravitreal and Intracameral DEX in NPDR
Key facts
- Where
- Nantong, ChinaSee the site
- Phase
- Phase 3
Where in China
- Eye Institute, Affiliated Hospital of Nantong UniversityNantong, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Affiliated Hospital of Nantong University
- Trial code
- NCT06951087
- Record updated
- 30 April 2025
- Original description
To investigate the effects of intravitreal and intracameral injection of dexamethasone during cataract phacoemulsification in patients with mild to moderate non-proliferative diabetic retinopathyRead full original descriptionShow less
Effect of Intravitreal and Intracameral Injection of Dexamethasone Sodium Phosphate on Mild to Moderate NPDR During Cataract Phacoemulsification
To investigate the effects of intravitreal and intracameral injection of dexamethasone during cataract phacoemulsification in patients with mild to moderate non-proliferative diabetic retinopathy
Inclusion: type 2 diabetic cataracts patients who were diagnosed with mild to moderate NPDR.
Exclusion: -.